Utilization of implantable defibrillators in Africa

R N Scott Millar1, B M Mayosi

  • 1Cardiac Clinic, Division of Cardiology, Department of Medicine, Groote Schuur Hospital and the University of Cape Town, Cape Town, South Africa. rsmillar@uctgsh1.uct.ac.za

Cardiac Electrophysiology Review
|May 27, 2003
PubMed

Insights

Sub-Saharan Africa faces significant disease burdens, with limited access to advanced cardiac care like implantable cardiovertor defibrillators (ICDs). South Africa leads in ICDs, but public access remains scarce, highlighting major healthcare disparities.

Area of Science:

  • Cardiology and cardiac surgery in Sub-Saharan Africa.
  • Public health challenges in developing regions.

Background:

  • Sub-Saharan Africa is disproportionately affected by diseases of poverty, including HIV/AIDS.
  • Healthcare expenditure is unevenly distributed, with a small percentage of the population consuming a large share, primarily through private medical insurance.
  • Public healthcare systems focus on primary care and sanitation, often at the expense of specialized services.

Purpose of the Study:

  • To assess the availability and accessibility of advanced cardiac services, specifically electrophysiology (EP) services, in Sub-Saharan Africa.
  • To highlight the disparities in cardiac care between South Africa and the rest of the region.
  • To examine the impact of healthcare funding models on specialized medical services.

Main Methods:

  • Review of existing data on cardiac device implantation rates (pacemakers and ICDs) in South Africa.
  • Analysis of healthcare expenditure and funding models in the region.
  • Description of the limited availability of electrophysiology services, including catheter ablation and ICD implantation, in state-funded and private sectors across Sub-Saharan Africa.

Main Results:

  • South Africa is the only country in Sub-Saharan Africa implanting implantable cardiovertor defibrillators (ICDs), with very few public hospital implants.
  • Pacemaker implantation rates in South Africa were 41/million in 2001.
  • Electrophysiology services, including catheter ablation and ICD implantation, are extremely limited, available in only one state hospital and three private centers in South Africa, with virtually none elsewhere in the region.
  • Funding diversions from tertiary hospitals have curtailed specialized cardiac services and led to a brain drain.

Conclusions:

  • Access to advanced cardiac care, including electrophysiology services and devices like ICDs, is severely limited in Sub-Saharan Africa.
  • Healthcare funding structures and resource allocation significantly impact the availability of specialized medical services.
  • There is a critical need to improve and expand tertiary cardiac care infrastructure and personnel training throughout the region.

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...